COVID-19

@theconversation.com 3 years ago

Why big firms are rarely toppled by corporate scandals – new research

@forbes.com 4 years ago

Down 40% From Recent Highs Can Inovio Pharmaceuticals Stock Rebound?

@forbes.com 4 years ago

Here’s Why Perrigo Stock May See Higher Levels In The Near Term

@forbes.com 4 years ago

ACADIA Pharmaceuticals Stock Now Looks Oversold At $27 Levels

@forbes.com 4 years ago

Should You Buy Mercury Systems At Around $50 Levels?

@forbes.com 4 years ago

Here’s Why Biogen Stock Can Offer Over 35% Gains

@forbes.com 4 years ago

Should You Buy uniQure Stock At $30?

@forbes.com 4 years ago

Low Marketing Impact: Omnicom Group Stock Will Not Return To Pre-Covid Level